Source: Health Canada shortage reports · Updated Jul 10, 2026
Some Quetiapine products are in shortage in Canada (47 of 117 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Dec 31, 2026.
An antipsychotic used to treat schizophrenia and bipolar disorder.
Products affected
47 / 117
In shortage since
Apr 1, 2017
Est. full return
Dec 31, 2026
Reports on file
321
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
DIN 02519763 · since Aug 7, 2025, est. end Mar 31, 2026 · Disruption of the manufacture of the drug.
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
Quetiapine is currently affected by 47 active shortage reports filed with Health Canada by TEVA CANADA LIMITED, MINT PHARMACEUTICALS INC, JAMP PHARMA CORPORATION, NORA PHARMA INC and 5 others.
The reported causes are: disruption of the manufacture of the drug; requirements related to complying with good manufacturing practices; apotex din 02501678 apo-quetiapine fumarate 300mg is available; apotex din 02501635 apo-quetiapine fumarate 25mg is available; apotex din 02501651 apo-quetiapine fumarate 200mg is available; apotex din 02501643 apo-quetiapine fumarate 100mg is available; the product is short-dated; the product is short dated; delay in shipping of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Quetiapine is classified under “ANTIPSYCHOTICS” (ATC N05AH).
Recent changes
Jul 10, 2026
New report filed
Jul 10, 2026
New report filed
Jul 10, 2026
New report filed
Jul 10, 2026
New report filed
Jul 10, 2026
Shortage resolved
Common questions
What is Quetiapine used for?
An antipsychotic used to treat schizophrenia and bipolar disorder.
When will Quetiapine be back in stock in Canada?
The latest manufacturer estimate is Dec 31, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Quetiapine in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Possible alternatives in the same class (antipsychotics)
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.